Actelion Pharmaceuticals, Ltd
Reporting payments is a legal requirement; large totals often reflect large product portfolios.
$1.6Mgeneral payments (2019-2025)
$39Kresearch payments (2019-2025)
288clinicians paid
General and research payments are shown separately, never blended. Research payments are often institution-directed and tied to clinical trials.
General payments by year
General payments only, as reported to CMS. Research payments are totaled above and not included in these bars.
Products most associated with its payments
Specialties it works with most
Clinicians with the largest reported totals
Often long-running consulting, speaking, or advisory relationships, which companies must report by law. A large total is not evidence of anything improper.
| Clinician | Location | Specialty | General payments (2019-2025) |
|---|---|---|---|
| Vallerie Mclaughlin | Ann Arbor, MI | Cardiovascular Disease | $218,572.87 |
| Hyong Kim | La Jolla, CA | Internal Medicine | $208,770.33 |
| Lewis Rubin | La Jolla, CA | Internal Medicine | $118,387.43 |
| Willis Maddrey | Dallas, TX | Hepatology | $104,828.49 |
| Richard Channick | Boston, MA | Critical Care Medicine (Internal Medicine) | $88,058.00 |
| Ioana Preston | Burlington, MA | Critical Care Medicine (Internal Medicine) | $84,804.08 |
| James Freston | Farmington, CT | Gastroenterology (Internal Medicine) | $64,448.58 |
| Paul Watkins | Chapel Hill, NC | Gastroenterology (Internal Medicine) | $48,850.00 |
| Robert Frantz | Rochester, MN | Advanced Heart Failure and Transplant Cardiology | $43,892.44 |
| Teresa De Marco | San Francisco, CA | Advanced Heart Failure and Transplant Cardiology | $37,151.05 |
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.